Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

HERON THERAPEUTICS, INC. /DE/ (HRTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

HERON THERAPEUTICS, INC. /DE/ (HRTX), most recent 12 months reported: revenue $151.18M, net loss $34.05M, free cash flow -$12.13M. Latest balance sheet on file: liquid cash $42.66M, total debt $142.65M, net cash -$99.99M. From SEC filings. Others in Pharmaceutical Preparations: LIFEVANTAGE CORP · Arbutus Biopharma Corp · Nuvation Bio Inc. · MACROGENICS, INC. · Karyopharm Therapeutics Inc. · Elite Pharmaceuticals, Inc. · Zevra Therapeutics, Inc. · LIFECORE BIOMEDICAL, INC.

Stock screener

Watchlist